This study demonstrates the utility of 18F-AV133 VMAT2 PET to indicate the loss of integrity of the nigrostriatal pathway in the striatum of RBD patients in the absence of a classical Parkinson’s motor phenotype. Here, SLC18A2 is linked to Parkinson disease.